EarningsQ3 2024 Earnings Report

Resmed (RMD) Q3 2024 Earnings Report

2 Followers

MX:RMD Q3 2024 EPS Results

Actual EPS$38.26

Consensus EPS$34.61

Beat/MissBeat by +$3.65

One Year Ago EPS$30.18

Actual Revenue$21.50B

Expected Revenue$21.09B

Beat/MissBeat by +$409.43M

YoY Revenue Growth+7.17%

QuarterQ3 2024

Date04/25/2024

TimeAfter Close

Conference CallThursday, April 25, 2024

MX:RMD Upcoming Earnings

Resmed's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

MX:RMD Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2027 (Q1)	48.16 / -	45.804	―
Aug 06, 2026	2026 (Q4)	51.97 / 52.99	45.804	15.69% (+7.18)
Apr 30, 2026	2026 (Q3)	50.20 / 51.37	42.571	20.68% (+8.80)
Jan 29, 2026	2026 (Q2)	49.31 / 50.47	43.649	15.64% (+6.83)
Oct 30, 2025	2026 (Q1)	45.21 / 45.80	39.517	15.91% (+6.29)
Jul 31, 2025	2025 (Q4)	44.76 / 45.80	37.362	22.60% (+8.44)
Apr 23, 2025	2025 (Q3)	42.71 / 42.57	38.26	11.27% (+4.31)
Jan 30, 2025	2025 (Q2)	41.60 / 43.65	33.769	29.26% (+9.88)
Oct 24, 2024	2025 (Q1)	36.89 / 39.52	29.458	34.15% (+10.06)
Aug 01, 2024	2024 (Q4)	37.42 / 37.36	28.74	30.00% (+8.62)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed